Pharmos(PARS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Pharmos(PARS)

PARS 2.700

+13.6%

Jan 21 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Rick Strange who wrote (1116)	8/6/1998 1:45:00 PM
From: crysball	Read Replies (1) of 1491

Q3-98 EUROPEAN LAUNCH OF LOTEMAX & ALREX Ariella, could you clarify the UK and Netherlands launches you mentioned in post 1115. Does PARS/BOL have regulatory approvals yet, as I've not seen these approvals announced? Secondly, history says there is a lag between approval date and product launch (The FDA approved Lotemax/Alrex 3/15 but it was June before BOL could get product out the door and the salesforce trained) and to me launch means product rolled out into the hands (eyes) of consumers. Also any thoughts on whether filling the distribution pipeline in Europe might help Q3 & beyond, as approvals in Europe are country by country. Do you happen to know if PARS cold license a CIS (formerly Soviet Union) Pharmaceutical Mfg. for Alrex or Lotemax within the limits of the BOL license.......i.e. is the BOL license by continent or by country? Your concise, information-packed reports are greatly appreciated by this reader. Best Regards, Neil

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next